Pontifax Venture Capital

Pontifax Venture Capital

Israeli venture capital firm funding Israeli bio-pharmaceutical and life science companies.

Pontifax Venture Capital is a venture capital firm established in 2004. The firm was founded by Ran Nussbaum and Tomer Kariv. It is based in Herzliya, Israel. As of March 2019, Pontifax Venture Capital has 42 active companies in its portfolio and has sold off its shares in 27 companies. It has most recently invested on Keros Therapeutics in January 2019, a bio-pharmaceutical company developing therapeutics for rare muscle disorders.

Funding

Pontifax Venture Capital funds companies at various stages of development, from early stage to growth capital. It specializes in funding companies that are based in Israel. The firm prefers to fund companies operating in the pharmaceutical and life science industry sectors. Since January 2016, the firm has managed to raise $585 million through three funding rounds. Its most recent funding round was held in November 2018, amassing $170 million.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.

Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug.

LogicBio Therapeutics is a Cambridge, Massachusetts-based company.

11 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Ohad Hammer

Partner

Ran Nussbaum

Managing Partner/Partner/Founder

Tomer Kariv

Chief Executive Officer/Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

89bio

ABAC Therapeutics

Dynacure

Horama

Keros Therapeutics

Step Pharma

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.